AUBAGIO® (teriflunomide) – Real-World Considerations
This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.
Adverse event reporting can be found at the bottom of the page.
A multi-channel learning journey providing knowledge, training and practical tools to empower MS nurses to implement change.
MAT-XU-2305082 (v1.0) Date of preparation: November 2023